
Regeneron Pharmaceuticals REGN
$ 703.23
2.46%
Quarterly report 2026-Q1
added 04-29-2026
Regeneron Pharmaceuticals Cash Conversion Cycle 2011-2026 | REGN
Annual Cash Conversion Cycle Regeneron Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 152 | 153 | 153 | 170 | 104 | 112 | 589 | 906 | 626 | 443 | 221 | 184 | 174 | 139 | -1.14 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 906 | -1.14 K | 199 |
Quarterly Cash Conversion Cycle Regeneron Pharmaceuticals
| 2026-Q1 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 144 | 139 | 176 | 145 | 141 | 157 | 145 | 148 | 151 | - | 86.2 | 77.3 | 167 | - | 165 | 99.2 | 150 | 155 | 164 | 192 | 155 | 103 | 110 | 121 | 127 | 81.6 | 94.5 | 97.8 | 98.5 | 88.7 | 93.6 | 95.5 | 99.7 | 99.9 | 100 | 101 | 94.8 | 95.8 | 92.5 | 105 | 99.3 | 84.1 | 93 | 101 | 111 | 118 | 120 | 157 | 143 | 131 | 127 | 178 | 122 | 21 | 25.1 | 23.9 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 192 | 21 | 117 |
Cash Conversion Cycle of other stocks in the Biotechnology industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
209 | $ 9.33 | 1.41 % | $ 603 M | ||
|
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
-400 | $ 0.87 | -2.13 % | $ 6.4 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
257 | $ 22.38 | 0.81 % | $ 3.71 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
Galapagos NV
GLPG
|
67.1 | $ 28.15 | 1.04 % | $ 2.69 B | ||
|
Advaxis
ADXS
|
-143 K | - | -9.65 % | $ 45.9 M | ||
|
Grifols, S.A.
GRFS
|
0.000171 | $ 8.22 | 3.92 % | $ 6.83 B | ||
|
Harmony Biosciences Holdings
HRMY
|
20.4 | $ 30.95 | -0.34 % | $ 1.78 B | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
ImmuCell Corporation
ICCC
|
213 | $ 8.43 | -0.12 % | $ 76.1 M | ||
|
Incyte Corporation
INCY
|
-54.7 | $ 98.55 | -0.55 % | $ 19.2 B | ||
|
InMed Pharmaceuticals
INM
|
184 | $ 0.71 | 1.27 % | $ 1.74 M | ||
|
Innoviva
INVA
|
24.6 | $ 22.97 | -0.35 % | $ 1.55 B | ||
|
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
Jaguar Health
JAGX
|
289 | $ 7.34 | -6.79 % | $ 17.1 M | ||
|
AIkido Pharma
AIKI
|
-1.92 | - | 1.93 % | $ 17.4 M | ||
|
KalVista Pharmaceuticals
KALV
|
-816 | $ 26.68 | 0.02 % | $ 1.44 B | ||
|
Kamada Ltd.
KMDA
|
163 | $ 8.16 | 0.68 % | $ 260 M | ||
|
Krystal Biotech
KRYS
|
109 | $ 260.24 | 0.11 % | $ 7.53 B | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
77.8 | $ 220.06 | -2.13 % | $ 4.02 B | ||
|
Liquidia Corporation
LQDA
|
65.5 | $ 38.41 | 0.67 % | $ 3.31 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-2.85 K | - | -11.43 % | $ 502 K | ||
|
Aquestive Therapeutics
AQST
|
-172 | $ 4.08 | 0.62 % | $ 436 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Aridis Pharmaceuticals
ARDS
|
59 | - | 17.91 % | $ 11.1 M | ||
|
Arcutis Biotherapeutics
ARQT
|
158 | $ 23.15 | 3.49 % | $ 2.95 B |